Bernstein downgraded Thermo Fisher to Market Perform from Outperform. The analyst says “more tough days are ahead” for tools and diagnostics companies in 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TMO:
- Thermo Fisher halts sales of DNA technology in Tibet, WSJ says
- Galapagos enters GMP manufacturing agreement with Thermo Fisher
- GlycoMimetics in manufacturing pact with Thermo Fisher for uproleselan
- HSBC Sees Opportunity in These 2 Biopharma Giants Ahead of the 2024 Elections
- Hamilton Thorne CEO David Wolf retires, Ekaterina Torchilin to succeed